Curaleaf Holdings (CURLF) Common Equity (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Common Equity of $69.8 million for Q1 2026, up 214.31% year-over-year from $22.2 million in Q1 2025, and down 90.77% quarter-over-quarter from $756.3 million in Q4 2025.
Curaleaf Holdings (CURLF) Common Equity (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Common Equity history runs 8 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Common Equity rose 214.31% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (up 214.31% YoY), while the FY2025 annual figure was $756.3 million, down 12.18% from the prior year.
- Common Equity for Q1 2026 stood at $69.8 million, down from $756.3 million in the prior quarter.
- The five-year high for Common Equity was $1805.5 billion in Q1 2022, with the low at -$370.1 million in Q4 2022.
- The 5-year median for Common Equity is $910.1 million (2024), against an average of $113.5 billion.
- Peak annual rise in Common Equity reached 112316.97% in 2022, while the deepest fall reached 123.94% in 2022.
- Curaleaf Holdings' Common Equity stood at -$370.1 million in 2022, then jumped by 383.88% to $1.1 billion in 2023, then slipped by 18.03% to $861.2 million in 2024, then declined by 12.18% to $756.3 million in 2025, then tumbled by 90.77% to $69.8 million in 2026.
- Business Quant data shows CURLF's Common Equity at $69.8 million in Q1 2026, $756.3 million in Q4 2025, and -$171.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 867.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 867.46 Mn |
| Mar 31, 2026 | 69.80 Mn |
| Dec 31, 2025 | 756.35 Mn |
| Sep 30, 2025 | -171.25 Mn |
| Jun 30, 2025 | -114.22 Mn |
| Mar 31, 2025 | -61.06 Mn |
| Dec 31, 2024 | 861.21 Mn |
| Sep 30, 2024 | 958.92 Mn |
| Jun 30, 2024 | 992.84 Mn |
| Mar 31, 2024 | -48.31 Mn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 1.09 Bn |
| Jun 30, 2023 | 1.18 Bn |
| Dec 31, 2022 | -370.10 Mn |
| Sep 30, 2022 | 1.71 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 1,805.54 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.76 Bn |
| Jun 30, 2021 | 1.81 Bn |